2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines

Saved in:

Bibliographic Details
Published in:	Circulation (New York, N.Y.) Vol. 139; no. 25; p. e1046
Main Authors:	Grundy, Scott M, Stone, Neil J, Bailey, Alison L, Beam, Craig, Birtcher, Kim K, Blumenthal, Roger S, Braun, Lynne T, de Ferranti, Sarah, Faiella-Tommasino, Joseph, Forman, Daniel E, Goldberg, Ronald, Heidenreich, Paul A, Hlatky, Mark A, Jones, Daniel W, Lloyd-Jones, Donald, Lopez-Pajares, Nuria, Ndumele, Chiadi E, Orringer, Carl E, Peralta, Carmen A, Saseen, Joseph J, Smith, Jr, Sidney C, Sperling, Laurence, Virani, Salim S, Yeboah, Joseph
Format:	Journal Article
Language:	English
Published:	United States 18.06.2019
Subjects:	Anticholesteremic Agents - adverse effects Anticholesteremic Agents - therapeutic use Biomarkers - blood Cardiology - standards Cardiovascular Diseases - blood Cardiovascular Diseases - diagnosis Cardiovascular Diseases - epidemiology Cardiovascular Diseases - prevention & control Cholesterol - blood Consensus Evidence-Based Medicine - standards Humans Hyperlipidemias - blood Hyperlipidemias - diagnosis Hyperlipidemias - drug therapy Hyperlipidemias - epidemiology Risk Assessment Risk Factors Treatment Outcome cardiovascular disease patient compliance risk assessment lipids drug therapy risk reduction discussion hydroxymethylglutaryl-CoA reductase inhibitors/statins risk treatment discussion, secondary prevention proprotein convertase subtilisin/kexin type 9 inhibitor (PCSK9) inhibitors biomarkers, coronary artery calcium score diabetes mellitus hypercholesterolemia pharmacological AHA Scientific Statements Guidelines cholesterol, LDL-cholesterol ezetimibe primary prevention
ISSN:	1524-4539, 1524-4539
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!